PerkinElmer Receives 2008 Life Science Industry Award for Achievement in High Throughput Screening
News Jun 13, 2008
PerkinElmer, Inc. has announced that it has received top honors in the Life Science Industry Awards for High Throughput Screening (HTS) and Analysis Systems.
For the second consecutive year, the Company was named a winner in the Life Science Industry Awards, which are determined based on the input of nearly 4,500 scientists worldwide, and recognize life science companies offering best-in-class technology and service over the past year.
"We are honored to once again be recognized for our contributions to High Throughput Screening by the worldwide scientific community,” said Dr. Richard M. Eglen, president, Bio-discovery, PerkinElmer, Inc.
“What makes this award special, apart from the fact that PerkinElmer has won this category two years running, is that scientists in cutting-edge research labs clearly recognize that our solutions continue to provide them with the critical technology and support they need to enable their work. We remain committed to serving these customers and extending our leadership in HTS technologies for advanced cellular research and drug discovery.”
“The results of this year's voting confirm the Winners' continued commitment to excellence in the technologies and services they deliver to their scientific customers," said Bill Kelly, president, BioInformatics, LLC. "PerkinElmer has won this category again because scientists clearly value the Company’s integrated, powerful platforms for drug discovery. One of their key strengths is in the percentage of their customers who say it’s ‘highly likely’ that they re-purchase HTS solutions from PerkinElmer.”
PerkinElmer offers a portfolio of enabling HTS technologies including cell-based and biological assays and reagents, detection instruments, microplates and automated liquid handling platforms. These technologies are designed to collectively provide a complete solution by delivering versatility, reliability, performance and the speed for HTS.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Rapid Test Helps with Administering the "Correct" DrugNews
In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018